Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2026-04-30
• Last 15 days FTD volume: £4.29 M
• Last 3 months FTD volume: £11.48 M
• Last 12 months FTD volume: £23.62 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	£57.33 M	£0.15 B	🇺🇸 USA
Thermo Fisher Scientific TMO	£5.38 M	£56.57 M	🇺🇸 USA
General Electric GE	£50.81 M	£0.24 B	🇺🇸 USA
Bristol-Myers Squibb BMY	£21.15 M	£68.65 M	🇺🇸 USA
Sangamo Therapeutics SGMO	£0.62 M	£7.11 M	🇺🇸 USA
Novavax NVAX	£5.09 M	£61.25 M	🇺🇸 USA
Neurocrine Biosciences NBIX	£2.88 M	£15.31 M	🇺🇸 USA
Bio-Techne TECH	£17.26 M	£32.98 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	£3.79 M	£16.56 M	🇺🇸 USA
Charles River Laboratories CRL	£16.63 M	£0.11 B	🇺🇸 USA